The rate of overdiagnosis inextricably linked to prostate-specific antigen-based screening for prostate cancer can be quantified in several ways, but what is the practicable message?
- PMID: 24486022
- DOI: 10.1016/j.eururo.2014.01.016
The rate of overdiagnosis inextricably linked to prostate-specific antigen-based screening for prostate cancer can be quantified in several ways, but what is the practicable message?
Comment on
-
Overdiagnosis and overtreatment of prostate cancer.Eur Urol. 2014 Jun;65(6):1046-55. doi: 10.1016/j.eururo.2013.12.062. Epub 2014 Jan 9. Eur Urol. 2014. PMID: 24439788 Free PMC article. Review.
Similar articles
-
Overdiagnosis and overtreatment of prostate cancer.Eur Urol. 2014 Jun;65(6):1046-55. doi: 10.1016/j.eururo.2013.12.062. Epub 2014 Jan 9. Eur Urol. 2014. PMID: 24439788 Free PMC article. Review.
-
Prostate-specific antigen testing in france.JAMA Intern Med. 2013 Nov 25;173(21):2014. doi: 10.1001/jamainternmed.2013.10405. JAMA Intern Med. 2013. PMID: 24276059 No abstract available.
-
Why I will continue to screen prostate-specific antigen for myself and other appropriate men.JAMA Intern Med. 2014 Jan;174(1):164. doi: 10.1001/jamainternmed.2013.11106. JAMA Intern Med. 2014. PMID: 24394929 No abstract available.
-
Why I will continue to screen prostate-specific antigen for myself and other appropriate men--reply.JAMA Intern Med. 2014 Jan;174(1):164. doi: 10.1001/jamainternmed.2013.11095. JAMA Intern Med. 2014. PMID: 24394931 No abstract available.
-
Prostate-specific antigen-based prostate cancer screening: Past and future.Int J Urol. 2015 Jun;22(6):524-32. doi: 10.1111/iju.12750. Epub 2015 Apr 6. Int J Urol. 2015. PMID: 25847604 Review.
Cited by
-
Eclipsed by the Prostate: Expanding Testicular Cancer Scholarship Through Years of Potential Life Lost and Economic Productivity.Am J Mens Health. 2017 May;11(3):674-677. doi: 10.1177/1557988316675794. Epub 2016 Oct 27. Am J Mens Health. 2017. PMID: 27789809 Free PMC article.
-
From molecular mechanisms of prostate cancer to translational applications: based on multi-omics fusion analysis and intelligent medicine.Health Inf Sci Syst. 2023 Dec 18;12(1):6. doi: 10.1007/s13755-023-00264-5. eCollection 2024 Dec. Health Inf Sci Syst. 2023. PMID: 38125666 Review.
-
What chance do we have to decrease prostate cancer overdiagnosis and overtreatment? A narrative review.Acta Biomed. 2019 Dec 23;90(4):423-426. doi: 10.23750/abm.v90i4.9070. Acta Biomed. 2019. PMID: 31910165 Free PMC article. Review.
-
Multivariable risk-based patient selection for prostate biopsy in a primary health care setting: referral rate and biopsy results from a urology outpatient clinic.Transl Androl Urol. 2018 Feb;7(1):27-33. doi: 10.21037/tau.2017.12.11. Transl Androl Urol. 2018. PMID: 29594017 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical